In previous papers, we demonstrated that NT4 very selectively binds to human cancer tissues in different malignancies and can efficiently and selectively deliver drugs or liposomes for cancer cell imaging or therapy, in vitro and in vivo [12–17]. The gene discussed is NTF4; the disease is cancer.